Compare MasTec Inc (MTZ) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MasTec Inc vs Zoetis Inc — how do they compare? MasTec Inc trades at $212.65 (market cap $17.40B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is the larger of the two by market cap, and Zoetis Inc pays a 2.9% dividend while MasTec Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold MasTec Inc for 23 Days and Zoetis Inc for 70 Days on average.
| MTZ | ZTS | |
|---|---|---|
Market Cap | $17.40B | $30.20B |
Volume | 1,415,821 | 6,175,327 |
Sector | Industrials | Health |
52-Week High | $437.51 | $147.53 |
52-Week Low | $190.08 | $69.09 |
Typical Hold Time | 23 Days | 70 Days |
Enterprise Value | $20.32B | $37.76B |
Dividend Yield | — | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MasTec (MTZ) trades at $216.66, down 3.0% on the day, amid bearish technical signals despite strong analyst support. The stock shows mixed earnings performance with recent Q2 2026 EPS missing expectations, but maintains robust revenue growth projections and a record $21.4B backlog. Current valuation metrics include a P/E of 34.5 and P/S of 1.06, while profitability metrics show a 3.07% net income margin and 15.39% ROE.
The investment outlook remains positive based on strong analyst consensus (88.9% buy ratings) and a $408.58 price target, representing significant upside potential. Key opportunities include infrastructure investment cycles and AI-driven data center demand, while risks include premium valuation, weak cash flow trends, and communications segment softness. The stock's current price near support levels offers potential entry points for long-term investors.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal despite mixed moving averages and oscillators. The company shows strong profitability with a 27.69% net income margin and 64.91% ROE, though recent quarterly earnings have been inconsistent. Analyst consensus is a $87.33 price target with no sell ratings. Recent news highlights near-term headwinds in U.S. companion animal sales but underscores long-term resilience and undervaluation.
ZTS presents a compelling value opportunity with a low P/E of 11.92 and robust margins, but faces risks from competitive pressures and volatile earnings. Upside potential exists if the company executes on international growth and maintains its industry-leading profitability, though investors should monitor Q3 2026 results for confirmation of recovery trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About MasTec Inc
MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.
Read more on MTZ →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
